Browsing: FDA

The Trump administration’s turbulent healthcare stewardship claimed another scalp with the departure of the 27th FDA Commissioner Dr. Marty Makary…

The operational structure of the FDA around centers, each governing a particular regulatory or scientific area, dates back more than…

With few treatments available for sickle cell disease, encouraging early clinical data for a Fulcrum Therapeutics drug made it one…

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended…

AbbVie’s strategy of growing in oncology by focusing on a particular type of targeted therapy is paying off with another…

A Daiichi Sankyo and AstraZeneca drug is now approved as a first-line treatment for a particularly difficult-to-treat type of breast…

Despite the availability of many hypertension drugs, many people find these medicines don’t work well enough. A first-in-class AstraZeneca medication…

An Aardvark Therapeutics clinical trial that has been on voluntary pause for nearly three months due to a safety signal…

Several drugs are available for mantle cell lymphoma, but relapse is common in this rare blood cancer. When that happens,…

A rare type of cancer affecting the bile ducts of the liver now has its first FDA-approved targeted treatment, an intravenously…